Latest Period
Q1 2026
Security Snapshot
Crescent Biopharma, Inc. - Ordinary Shares, par value $0.001 per share (CBIO) Institutional Ownership
CUSIP: 38000Q201
13F Institutional Holders and Ownership History from Q4 2025 to Q1 2026
Institutions Reporting
3
Shares (Excl. Options)
835,853
Price
$18.37
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Ordinary Shares, par value $0.001 per share
- Symbol
- CBIO on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 835,853
- Total 13F value
- $15,354,620
- Portfolio coverage rank
- 0%
- Share change
- +461,357
- Value change
- +$8,475,128
- Number of holders
- 3
- Shares outstanding
- 13,839,146
- SEC-reported price per share
- $18.37
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CBIO - Crescent Biopharma, Inc. - Ordinary Shares, par value $0.001 per share is tracked under CUSIP 38000Q201.
- 3 institutions reported positions in Q1 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 2 to 3 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $4,441,098 to $15,354,620.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 3 institutions filings for Q1 2026.
Security key
38000Q201
Latest holder period
Q1 2026
13F holders
3
13D/G owners
4
CIK / CUSIP context first
Open Q1 2026 holders
CBIO full holder history
CRESCENT BIOPHARMA, INC. SEC filings
CRESCENT BIOPHARMA, INC. company facts
CRESCENT BIOPHARMA, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 38000Q201:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
CBIO
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| 1Globe Capital LLC | 10% | +64% | $20,839,816 | +$7,729,886 | 1,425,432 | +59% | 1Globe Capital LLC | 07 Oct 2025 |
| FMR LLC | 10% | 1,414,190 | FMR LLC | 30 Jun 2025 | ||||
| Venrock Healthcare Capital Partners III, L.P. | 9.9% | 1,391,196 | Venrock Healthcare Capital Partners III, L.P. | 13 Jun 2025 | ||||
| Adage Capital Management, L.P. | 0.37% | 50,912 | Adage Capital Management, L.P. | 20 Jun 2025 |
As of 31 Mar 2026, 3 institutional investors reported holding 835,853 shares of Crescent Biopharma, Inc. - Ordinary Shares, par value $0.001 per share (CBIO). This represents 6% of the company’s total 13,839,146 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
2
Latest
Q1 2026
Rows shown
1-2 of 2